SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Lyra Therapeutics Q1 EPS $(0.60) Misses $(0.48) Estimate

Lyra Therapeutics (NASDAQ:LYRA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.48) by 25 percent. This is a 96.79 percent increase over losses of $(18.70) per share from

05/11/2021 16:23
Lyra Therapeutics (NASDAQ:LYRA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.48) by 25 percent. This is a 96.79 percent increase over losses of $(18.70) per share from the same period last year.